Asparaginase

CHEMBL2108989 Phase 4 Đã phê duyệt Enzyme
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

An enzyme that breaks down asparagine, an amino acid that certain cancer cells cannot produce on their own and depend on from the blood supply. By depleting asparagine, this therapy starves leukemia cells of a nutrient essential for their survival.

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

An enzyme that breaks down asparagine, an amino acid that certain cancer cells cannot produce on their own and depend on from the blood supply. By depleting asparagine, this therapy starves leukemia cells of a nutrient essential for their survival.

Yes, Asparaginase is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108989. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.